{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:25:18Z","timestamp":1792697118110,"version":"4.5.0"},"reference-count":41,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2022,6,10]],"date-time":"2022-06-10T00:00:00Z","timestamp":1654819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: The consumption of dietary supplements has increased over the last decades among pregnant women, becoming an efficient resource of micronutrients able to satisfy their nutritional needs during pregnancy. Furthermore, gestational drug administration might be necessary to treat several pregnancy complications such as hypertension. Folic acid (FA) and folate (FT) supplementation is highly recommended by clinicians during pregnancy, especially for preventing neural tube birth defects, while labetalol (LB) is a \u03b2-blocker commonly administered as a safe option for the treatment of pregnancy-related hypertension. Currently, the possible toxicity resulting from the co-administration of FA\/FT and LB has not been fully evaluated. In light of these considerations, the current study was aimed at investigating the possible in vitro cardio- and hepato-toxicity of LB-FA and LB-FT associations. Materials and Methods: Five different concentrations of LB, FA, FT, and their combination were used in myoblasts and hepatocytes in order to assess cell viability, cell morphology, and wound regeneration. Results: The results indicate no significant alterations in terms of cell viability and morphology in myoblasts (H9c2(2-1)) and hepatocytes (HepaRG) following a 72-h treatment, apart from a decrease in the percentage of viable H9c2(2-1) cells (~67%) treated with LB 150 nM\u2013FT 50 nM. Additionally, LB (50 and 150 nM)\u2013FA (0.2 nM) exerted an efficient wound regenerating potential in H9c2(2-1) myoblasts (wound healing rates were &gt;80%, compared to the control at 66%), while LB-FT (at all tested concentrations) induced no significant impairment to their migration. Conclusions: Overall, our findings indicate that LB-FA and LB-FT combinations lack cytotoxicity in vitro. Moreover, beneficial effects were noticed on H9c2(2-1) cell viability and migration from LB-FA\/FT administration, which should be further explored.<\/jats:p>","DOI":"10.3390\/medicina58060784","type":"journal-article","created":{"date-parts":[[2022,6,12]],"date-time":"2022-06-12T22:37:20Z","timestamp":1655073440000},"page":"784","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["In Vitro Toxicological Profile of Labetalol-Folic Acid\/Folate Co-Administration in H9c2(2-1) and HepaRG Cells"],"prefix":"10.3390","volume":"58","author":[{"given":"Robert","family":"Rednic","sequence":"first","affiliation":[{"name":"Faculty of Medicine, \u201cVictor Babes\u201d University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square No.2, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iasmina","family":"Marcovici","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, \u201cVictor Babes\u201d University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square No.2, 300041 Timisoara, Romania"},{"name":"Research Center for Pharmaco-Toxicological Evaluations, Faculty of Pharmacy, \u201cVictor Babes\u201d University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square No.2, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3991-7583","authenticated-orcid":false,"given":"Razvan","family":"Dragoi","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, \u201cVictor Babes\u201d University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square No.2, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2295-1926","authenticated-orcid":false,"given":"Iulia","family":"Pinzaru","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, \u201cVictor Babes\u201d University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square No.2, 300041 Timisoara, Romania"},{"name":"Research Center for Pharmaco-Toxicological Evaluations, Faculty of Pharmacy, \u201cVictor Babes\u201d University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square No.2, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina Adriana","family":"Dehelean","sequence":"additional","affiliation":[{"name":"Faculty of Pharmacy, \u201cVictor Babes\u201d University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square No.2, 300041 Timisoara, Romania"},{"name":"Research Center for Pharmaco-Toxicological Evaluations, Faculty of Pharmacy, \u201cVictor Babes\u201d University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square No.2, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2117-0474","authenticated-orcid":false,"given":"Mirela","family":"Tomescu","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, \u201cVictor Babes\u201d University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square No.2, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9959-5718","authenticated-orcid":false,"given":"Diana Aurora","family":"Arnautu","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, \u201cVictor Babes\u201d University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square No.2, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius","family":"Craina","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, \u201cVictor Babes\u201d University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square No.2, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Gluhovschi","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, \u201cVictor Babes\u201d University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square No.2, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihaela","family":"Valcovici","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, \u201cVictor Babes\u201d University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square No.2, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aniko","family":"Manea","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, \u201cVictor Babes\u201d University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square No.2, 300041 Timisoara, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,6,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Xiang, C., Luo, J., Yang, G., Sun, M., Liu, H., Yang, Q., Ouyang, Y., Xi, Y., Yong, C., and Khan, M.J. (2022). Dietary Supplement Use during Pregnancy: Perceptions versus Reality. Int. J. Environ. Res. Public Health, 19.","DOI":"10.3390\/ijerph19074063"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Ballest\u00edn, S.S., Campos, M.I.G., Ballest\u00edn, J.B., and Bartolom\u00e9, M.J.L. (2021). Is Supplementation with Micronutrients Still Necessary during Pregnancy? A Review. Nutrients, 13.","DOI":"10.3390\/nu13093134"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/AOG.0000000000003657","article-title":"Dietary Supplement Use and Its Micronutrient Contribution During Pregnancy and Lactation in the United States","volume":"135","author":"Jun","year":"2020","journal-title":"Obstet. Gynecol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1365-277X.2011.01216.x","article-title":"Uptake of folic acid supplements before and during pregnancy: Focus group analysis of women\u2019s views and experiences","volume":"25","author":"Barbour","year":"2012","journal-title":"J. Hum. Nutr. Diet."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/nyas.13499","article-title":"Safety of folic acid","volume":"1414","author":"Field","year":"2018","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_6","first-page":"52","article-title":"Folic Acid supplementation and pregnancy: More than just neural tube defect prevention","volume":"4","author":"Greenberg","year":"2011","journal-title":"Rev. Obstet. Gynecol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Shulpekova, Y., Nechaev, V., Kardasheva, S., Sedova, A., Kurbatova, A., Bueverova, E., Kopylov, A., Malsagova, K., Dlamini, J.C., and Ivashkin, V. (2021). The Concept of Folic Acid in Health and Disease. Molecules, 26.","DOI":"10.3390\/molecules26123731"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10545-010-9128-0","article-title":"Folate and cancer: How DNA damage, repair and methylation impact on colon carcinogenesis","volume":"34","author":"Duthie","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"480","DOI":"10.3109\/00498254.2013.845705","article-title":"Folate, folic acid and 5-methyltetrahydrofolate are not the same thing","volume":"44","author":"Scaglione","year":"2014","journal-title":"Xenobiotica"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1053\/j.semperi.2015.08.003","article-title":"Pharmacokinetics of drugs in pregnancy","volume":"39","author":"Feghali","year":"2015","journal-title":"Semin. Perinatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1097\/HJH.0000000000000134","article-title":"Antihypertensive drugs methyldopa, labetalol, hydralazine, and clonidine improve trophoblast interaction with endothelial cellular networks in vitro","volume":"32","author":"Xu","year":"2014","journal-title":"J. Hypertens."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1186\/s12884-021-03809-2","article-title":"Epidemiological trends of maternal hypertensive disorders of pregnancy at the global, regional, and national levels: A population-based study","volume":"21","author":"Wang","year":"2021","journal-title":"BMC Pregnancy Childbirth"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"211","DOI":"10.14310\/horm.2002.1582","article-title":"Pregnancy-Induced hypertension","volume":"14","author":"Kintiraki","year":"2015","journal-title":"Hormones (Athens)"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1161\/HYPERTENSIONAHA.119.14621","article-title":"Folic Acid Supplement Use and Increased Risk of Gestational Hypertension","volume":"76","author":"Li","year":"2020","journal-title":"Hypertension"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s00404-018-4823-4","article-title":"Supplementation of folic acid in pregnancy and the risk of preeclampsia and gestational hypertension: A meta-analysis","volume":"298","author":"Liu","year":"2018","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1053\/j.ackd.2013.01.014","article-title":"The Management of Hypertension in Pregnancy","volume":"20","author":"Kattah","year":"2013","journal-title":"Adv. Chronic Kidney Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ccl.2020.09.005","article-title":"Hypertensive Disorders of Pregnancy","volume":"39","author":"Khedagi","year":"2021","journal-title":"Cardiol. Clin."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s40265-014-0187-7","article-title":"Drug treatment of hypertension in pregnancy","volume":"74","author":"Brown","year":"2014","journal-title":"Drugs"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1517\/14740338.2015.998197","article-title":"Labetalol for hypertension in pregnancy","volume":"14","author":"Magee","year":"2015","journal-title":"Expert Opin. Drug Saf."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.sjbs.2020.10.027","article-title":"Ginger extract attenuates labetalol induced apoptosis, DNA damage, histological and ultrastructural changes in the heart of rat fetuses","volume":"28","author":"Gobara","year":"2021","journal-title":"Saudi J. Biol. Sci."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3389\/fcvm.2018.00050","article-title":"Use of Antihypertensive Drugs During Preeclampsia","volume":"5","author":"Odigboegwu","year":"2018","journal-title":"Front. Cardiovasc. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e210","DOI":"10.1055\/s-0040-1713789","article-title":"Labetalol-Induced Hepatotoxicity during Pregnancy: A Case Report","volume":"10","author":"Whelan","year":"2020","journal-title":"AJP Rep."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Maghiari, A.L., Coricovac, D., Pinzaru, I.A., Maca\u0219oi, I.G., Marcovici, I., Simu, S., Navolan, D., and Dehelean, C. (2020). High Concentrations of Aspartame Induce Pro-Angiogenic Effects in Ovo and Cytotoxic Effects in HT-29 Human Colorectal Carcinoma Cells. Nutrients, 12.","DOI":"10.3390\/nu12123600"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Kis, A.M., Macasoi, I., Paul, C., Radulescu, M., Buzatu, R., Watz, C.G., Cheveresan, A., Berceanu, D., Pinzaru, I., and Dinu, S. (2022). Methotrexate and Cetuximab-Biological Impact on Non-Tumorigenic Models: In Vitro and In Ovo Assessments. Medicina (Kaunas), 58.","DOI":"10.3390\/medicina58020167"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1053\/j.semperi.2015.08.011","article-title":"A review of oral labetalol and nifedipine in mild to moderate hypertension in pregnancy","volume":"39","author":"Clark","year":"2015","journal-title":"Semin. Perinatol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1007\/s10616-016-9957-2","article-title":"The effect of a number of H9C2 rat cardiomyocytes passage on repeatability of cytotoxicity study results","volume":"68","author":"Witek","year":"2016","journal-title":"Cytotechnology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.vascn.2007.06.001","article-title":"H9c2 cell line is a valuable in vitro model to study the drug metabolizing enzymes in the heart","volume":"56","author":"Zordoky","year":"2007","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1080\/00498254.2019.1590882","article-title":"Cytotoxicity of safrole in HepaRG cells: Studies on the role of CYP1A2-mediated ortho-quinone metabolic activation","volume":"49","author":"Hu","year":"2019","journal-title":"Xenobiotica"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Blidisel, A., Marcovici, I., Coricovac, D., Hut, F., Dehelean, C.A., and Cretu, O.M. (2021). Experimental models of hepatocellular carcinoma\u2014A preclinical perspective. Cancers, 13.","DOI":"10.3390\/cancers13153651"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/jat.3711","article-title":"Innovation for hepatotoxicity in vitro research models: A review","volume":"39","author":"Han","year":"2019","journal-title":"J. Appl. Toxicol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1053\/j.semperi.2015.08.002","article-title":"Epidemiology of medications use in pregnancy","volume":"39","author":"Ayad","year":"2015","journal-title":"Semin. Perinatol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"88","DOI":"10.14390\/jsshp.1.88","article-title":"Umbilical cord blood concentrations of labetalol hydrochloride administered to patients with pregnancy induced hypertension, and subsequent neonatal findings","volume":"1","author":"Uematsu","year":"2013","journal-title":"Hypertens. Res. Pregnancy"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.3945\/ajcn.2010.29361","article-title":"Concentrations of unmetabolized folic acid and primary folate forms in pregnant women at delivery and in umbilical cord blood","volume":"92","author":"Obeid","year":"2010","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"S424","DOI":"10.21037\/cdt.2019.02.03","article-title":"Folate supplementation for prevention of congenital heart defects and low birth weight: An update","volume":"9","author":"Obeid","year":"2019","journal-title":"Cardiovasc. Diagn. Ther."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"8506","DOI":"10.1038\/srep08506","article-title":"Maternal folic acid supplementation and the risk of congenital heart defects in offspring: A meta-analysis of epidemiological observational studies","volume":"5","author":"Feng","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s13287-021-02252-6","article-title":"Mitochondria and metabolic transitions in car-diomyocytes: Lessons from development for stem cell-derived cardiomyocytes","volume":"12","author":"Garbern","year":"2021","journal-title":"Stem Cell Res. Ther."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.clnu.2021.11.007","article-title":"Association of folate intake with cardiovascular-disease mortality and all-cause mortality among people at high risk of cardiovascular-disease","volume":"41","author":"Xu","year":"2022","journal-title":"Clin. Nutr."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1080\/13880209.2017.1299768","article-title":"Folic acid ameliorates celecoxib car-diotoxicity in a doxorubicin heart failure rat model","volume":"55","author":"Ahmad","year":"2017","journal-title":"Pharm. Biol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1111\/jcmm.13231","article-title":"Folic acid reduces doxorubicin-induced cardiomyopathy by modulating endothelial nitric oxide synthase","volume":"21","author":"Octavia","year":"2017","journal-title":"J. Cell. Mol. Med."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"10062","DOI":"10.1038\/s41598-019-46448-6","article-title":"The \u03b22-adrenergic receptor antagonist ICI-118,551 blocks the constitutively activated HIF signalling in hemangioblastomas from von Hippel-Lindau disease","volume":"9","author":"Cuesta","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"914","DOI":"10.3906\/sag-1901-231","article-title":"Role of mesenchymal stem cell-derived soluble factors and folic acid in wound healing","volume":"49","author":"Pakdemirli","year":"2019","journal-title":"Turk. J. Med. Sci."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/58\/6\/784\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:27:31Z","timestamp":1760138851000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/58\/6\/784"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,10]]},"references-count":41,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,6]]}},"alternative-id":["medicina58060784"],"URL":"https:\/\/doi.org\/10.3390\/medicina58060784","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,10]]}}}